Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$6.74B |
| 2 |
JPMorgan Chase
JPM
|
+$4.88B |
| 3 |
ExxonMobil
XOM
|
+$4.87B |
| 4 |
Wells Fargo
WFC
|
+$4.74B |
| 5 |
Microsoft
MSFT
|
+$4.63B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.04% |
| 2 | Financials | 14.83% |
| 3 | Technology | 12.65% |
| 4 | Energy | 11.87% |
| 5 | Industrials | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Charles River Laboratories
CRL
$13.3B
| $89.9M | 0.03% |
+2,191,559
| New | +$93.9M |
|
502
Acco Brands
ACCO
$393M
| $89.3M | 0.03% |
+14,036,751
| New | +$94.8M |
|
|
AVB
503
DELISTED
AvalonBay Communities
AVB
| $89.2M | 0.03% |
+661,466
| New | +$88.4M |
|
504
Transocean
RIG
$6.38B
| $88.9M | 0.03% |
+1,853,250
| New | +$94.5M |
|
|
IRBT
505
DELISTED
iRobot
IRBT
| $88.8M | 0.03% |
+2,231,897
| New | +$69.7M |
|
|
HNT
506
DELISTED
HEALTH NET INC
HNT
| $88.4M | 0.03% |
+2,778,844
| New | +$83.7M |
|
507
Edwards Lifesciences
EW
$49.7B
| $88.1M | 0.03% |
+7,866,936
| New | +$93.1M |
|
|
QEP
508
DELISTED
QEP RESOURCES, INC.
QEP
| $88M | 0.03% |
+3,167,963
| New | +$91.9M |
|
509
United Therapeutics
UTHR
$21.7B
| $88M | 0.03% |
+1,336,812
| New | +$86.1M |
|
|
HUB.B
510
DELISTED
HUBBELL INC CL-B
HUB.B
| $87.7M | 0.03% |
+885,643
| New | +$85.7M |
|
|
FLTX
511
DELISTED
Fleetmatics Group PLC
FLTX
| $86.9M | 0.03% |
+2,616,417
| New | +$70.4M |
|
|
AAT
512
American Assets Trust
AAT
$1.33B
| $86.4M | 0.03% |
+2,798,431
| New | +$92.4M |
|
513
Moody's
MCO
$82.2B
| $86.4M | 0.03% |
+1,417,231
| New | +$86M |
|
|
B
514
DELISTED
Barnes Group Inc.
B
| $86.2M | 0.03% |
+2,874,117
| New | +$83.1M |
|
|
DBD
515
DELISTED
Diebold Nixdorf Incorporated
DBD
| $86M | 0.03% |
+2,551,611
| New | +$79M |
|
516
Banco Bradesco
BBD
$36.3B
| $85.1M | 0.03% |
+16,685,983
| New | +$103M |
|
517
Mueller Industries
MLI
$14.1B
| $84.5M | 0.03% |
+13,398,320
| New | +$86.8M |
|
|
PPO
518
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $84.4M | 0.03% |
+2,094,776
| New | +$83.6M |
|
519
Steris
STE
$21B
| $83.9M | 0.03% |
+1,957,414
| New | +$84.2M |
|
520
VeriSign
VRSN
$25.9B
| $83.3M | 0.03% |
+1,865,057
| New | +$86.4M |
|
|
ESND
521
DELISTED
Essendant Inc.
ESND
| $83.2M | 0.03% |
+2,479,594
| New | +$85.6M |
|
|
ESL
522
DELISTED
Esterline Technologies
ESL
| $83M | 0.03% |
+1,147,668
| New | +$85.1M |
|
523
Amphenol
APH
$201B
| $82.7M | 0.03% |
+16,985,280
| New | +$81.3M |
|
|
ESRX
524
DELISTED
Express Scripts Holding Company
ESRX
| $82.6M | 0.03% |
+1,338,828
| New | +$80.6M |
|
|
WDR
525
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $82.4M | 0.03% |
+1,895,111
| New | +$83.5M |
|
Similar funds
Wellington Management Group's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Wellington Management Group, which disclosed 2,125 positions worth $306B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Merck: 150,849,570 shares worth $6.69B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2013 buy was Merck: 150,849,570 shares worth $6.69B.
- Wellington Management Group's ten largest holdings make up 15% of its $306B portfolio in Q2 2013.
- Wellington Management Group disclosed 2,125 positions in Q2 2013, its first 13F filing on record.
Based on Wellington Management Group's 13F filing for Q2 2013, filed 14 Aug 2013.